Search

Your search keyword '"Donnarumma, L."' showing total 181 results

Search Constraints

Start Over You searched for: Author "Donnarumma, L." Remove constraint Author: "Donnarumma, L."
181 results on '"Donnarumma, L."'

Search Results

2. P544 Ustekinumab safety and effectiveness in ulcerative colitis patients: results from a large real-life study

3. T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM “LONG VEDO” ITALIAN MULTICENTER STUDY

4. P505 Real word long-term efficacy and safety of vedolizumab in managing ulcerative colitis versus crohn’s disease: results from “long vedo” italian multicenter study

6. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

7. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

8. P583 Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: results from a large Italian cohort study

11. VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen

17. PRIORITIZZAZIONE DELLE SPECIE ALIENE MARINE ITALIANE PER L’IMPLEMENTAZIONE DI UNA LISTA DI SPECIE ALIENE INVASIVE DI RILEVANZA NAZIONALE AI SENSI DEL REGOLAMENTO EU 1143/2014 E DEL DECRETO LEGISLATIVO 230/2017

21. Roadmap to the management of marine invasive alien species in Europe: a prioritization exercise in a Mediterranean country

24. L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV

25. Prioritizing invasive alien species in Italy: screening of marine alien species

26. Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience

27. Effectiveness of Essential Oils Mixtures Based on Soy Emulsifier Against Powdery Mildew on Zucchini Plants

33. Evaluation of QoL as a predictor of chemotherapy-induced toxicity

34. Optimization of direct antiviral agent treatment schedule in hepatitis C virus genotype 3 infection: an Italian, multicentetric experience in real-life setting

35. Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)

40. Estensione di impiego di agrofarmaci su colture minori

43. Associated Benthic Fauna to the Vermetid Reefs along the Mediterranean Spanish Coast

48. FRI-280 - Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)

49. P729 HCV GENOTYPE 1A AND 1B: SIMILARITIES AND DIFFERENCES IN CLINICAL FEATURES, THERAPEUTIC OUTCOME AND PREDICTORS OF RESPONSE

50. P.17.8 CLINICAL FEATURES, THERAPEUTIC OUTCOME AND PREDICTOR OF RESPONSE IN HCV GENOTYPE 1A AND 1B: SIMILARITIES AND DIFFERENCES

Catalog

Books, media, physical & digital resources